Assessment of the Clinical and Ultrasound Response to Apremilast by Clinical Evaluation and by a Joint-periarticular-nail Ultrasound Index in Patients With Active Psoriatic Arthritis
Phase of Trial: Phase III
Latest Information Update: 19 Jun 2019
Price : $35 *
At a glance
- Drugs Apremilast (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- Acronyms APREMILAST
- 19 Jun 2019 Status changed from not yet recruiting to recruiting.
- 16 Oct 2017 Planned initiation date changed from 14 Aug 2017 to 2 Nov 2017.
- 21 Jun 2017 New trial record